Ceftizoxime
From Wikipedia, the free encyclopedia
|
Ceftizoxime
|
|
| Systematic (IUPAC) name | |
| (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)- 2-methoxyiminoacetyl]amino]-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
| Identifiers | |
| CAS number | 68401-82-1 (sodium salt) |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C13H13N5O5S2 |
| Mol. mass | 383.405 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Ceftizoxime is a parenteral third-generation cephalosporin.
|
||||||||||||||||||||

